Liberalizing hospital proximity requirements for children/young adults with low-burden B-ALL receiving tisagenlecleucel.

Creator(s)

Lauren E. Appell
Christina Baggott
Khanh Nguyen
Snehit Prabhu
Holly Pacenta
Samuel John
Vanessa A. Fabrizio
Christine L. Phillips
Jenna Rossoff
Julie-An Talano
Amy Moskop
Rachel Phelan
Susanne H C Baumeister
Michael R. Verneris
Erin Hall, Children's Mercy HospitalFollow
Gary Douglas Myers
Nicole A. Karras
Stacy L. Cooper
Muna Qayed
Sunil S. Raikar
Lena Winestone
Michelle Hermiston
Prakash Satwani
Christa Krupski
Amy K Keating
Danielle N. Friedman
Kevin J. Curran
Alex Hoover
Margaret L. MacMillan
Christen L. Ebens
Archana Ramgopal
April L. Rahrig
Crystal L. Mackall
Theodore W. Laetsch
Kevin McNerney
Liora M. Schultz

Document Type

Letter to the Editor

Publication Date

1-13-2026

Identifier

DOI: 10.1182/bloodadvances.2025017012; PMCID: PMC12804132

Journal Title

Blood Adv

Volume

10

Issue

1

First Page

106

Last Page

110

PubMed ID

41026960

Comments

Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution.

Publisher's Link: https://ashpublications.org/bloodadvances/article/10/1/106/547528/Liberalizing-hospital-proximity-requirements-for

Recommended Citation

Appell LE, Baggott C, Nguyen K, et al. Liberalizing hospital proximity requirements for children/young adults with low-burden B-ALL receiving tisagenlecleucel. Blood Adv. 2026;10(1):106-110. doi:10.1182/bloodadvances.2025017012